Oslo, 16 May 2024 - Navamedic ASA (OSE: NAVA), a Nordic pharma company and
reliable provider of high-quality products to hospitals and pharmacies, has
received confirmation of an extension of its contract with The Norwegian
Hospital Procurement Trust (Sykehusinnkjøp HF) for continued delivery of
antibiotics to Norwegian hospitals. The contract runs to 31 January 2027.

The contract is awarded by The Norwegian Hospital Procurement Trust on behalf of
the four health regions in Norway as part of the LIS tender programme (in
Norwegian: legemiddelinnkjøpssamarbeid) for antibiotics. The contract is an
extension of a contract which was originally entered into in 2022.

The contract runs from 1 February 2025 to 31 January 2027. Navamedic expects
that the renewed contract will contribute to a growth in the total antibiotic
portfolio revenues of more than 20 percent.

"We are proud to have been selected again as provider of antibiotics to
Norwegian hospitals, and we are excited to continue the great partnership we
have built with Sykehusinnkjøp. This contract underpins Navamedic's position as
a solid, trustworthy and responsible supplier of one of the world's most
important medicines," said Kathrine Gamborg Andreassen, CEO of Navamedic ASA.

Needed in surgeries as well as post-surgery treatment, access to safe
antibiotics that are produced in a responsible way is key to avoid the imminent
risk of antibiotic resistance. This is one reason why environmental criteria
were considered so important in additional to price, and why it weighed 30
percent in the LIS tender.

For further information, please contact:

Kathrine Gamborg Andreassen, CEO, Navamedic
Mobile: +47 951 78680
E-mail: kathrine@navamedic.com

Lars Hjarrand, CFO, Navamedic
Mobile: +47 917 62842
E-mail: lars.hjarrand@navamedic.com

About Navamedic ASA

Navamedic ASA is a Nordic pharma company and reliable provider of high-quality
products, delivered to hospitals and through pharmacies, meeting the specific
needs of patients and consumers by leveraging its highly scalable market access
platform, leading category competence and local knowledge. Navamedic is present
in all the Nordic countries, the Baltics and Benelux, with sales representation
in the UK and Greece. Navamedic is headquartered in Oslo, Norway, and listed on
the Oslo Stock  Exchange (ticker: NAVA).

For more information, please visit www.navamedic.com